Advances in proteomics methods for the analysis of exhaled breath condensate.
clinical
exhaled breath condensate
liquid chromatography
mass spectrometry
proteomics
Journal
Mass spectrometry reviews
ISSN: 1098-2787
Titre abrégé: Mass Spectrom Rev
Pays: United States
ID NLM: 8219702
Informations de publication
Date de publication:
27 Dec 2023
27 Dec 2023
Historique:
received:
11
12
2023
accepted:
13
12
2023
medline:
27
12
2023
pubmed:
27
12
2023
entrez:
27
12
2023
Statut:
aheadofprint
Résumé
The analysis of exhaled breath condensate (EBC) demonstrates a promising avenue of minimally invasive biopsies for diagnostics. EBC is obtained by cooling exhaled air and collecting the condensation to be utilized for downstream analysis using various analytical methods. The aqueous phase of breath contains a large variety of miscible small compounds including polar electrolytes, amino acids, cytokines, chemokines, peptides, small proteins, metabolites, nucleic acids, and lipids/eicosanoids-however, these analytes are typically present at minuscule levels in EBC, posing a considerable technical challenge. Along with recent improvements in devices for breath collection, the sensitivity and resolution of liquid chromatography coupled to online mass spectrometry-based proteomics has attained subfemtomole sensitivity, vastly enhancing the quality of EBC sample analysis. As a result, proteomics analysis of EBC has been expanding the field of breath biomarker research. We present an au courant overview of the achievements in proteomics of EBC, the advancement of EBC collection devices, and the current and future applications for EBC biomarker analysis.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 John Wiley & Sons Ltd.
Références
Aebersold, R., and M. Mann. 2003. “Mass Spectrometry-Based Proteomics.” Nature 422 (6928): 198-207. https://doi.org/10.1038/nature01511
Ahmadzai, H., S. Huang, R. Hettiarachchi, J.-L. Lin, P.S. Thomas, and Q. Zhang. 2013. “Exhaled Breath Condensate: A Comprehensive Update.” Clinical Chemistry and Laboratory Medicine 51 (7): 1343-1361. https://doi.org/10.1515/cclm-2012-0593
Alberg, A.J., M.V. Brock, J.G. Ford, J.M. Samet, and S.D. Spivack. 2013. “Epidemiology of Lung Cancer.” Chest 143 (5): e1S-e29S. https://doi.org/10.1378/chest.12-2345
Antczak, A., W. Plotrowski, J. Marczak, and M. Ciebuada. 2011. “Correlation between Eicosanoids in Bronchoalveolar Lavage Fluid and in Exhaled Breath Condensate.” Disease Markers 30 (5): 213-220.
Bach, P.B., J.N. Mirkin, T.K. Oliver, C.G. Azzoli, D.A. Berry, O.W. Brawley, T. Byers, et al. 2012. “Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review.” JAMA 307 (22): 2418. https://doi.org/10.1001/jama.2012.5521
Bianchi, F., F. Nicassio, M. Marzi, and E. Belloni. 2011. “A Serum Circulating MiRNA Diagnostic Test to Identify Asymptomatic High-Risk Individuals with Early-Stage Lung Cancer.” EMBO Molecular Medicine 3 (8): 495-503.
Bloemen, K., R. Van Den Heuvel, E. Govarts, J. Hooyberghs, V. Nelen, E. Witters, K. Desager, and G. Schoeters. 2011. “A New Approach to Study Exhaled Proteins as Potential Biomarkers for Asthma: Exhaled Biomarkers for Asthma.” Clinical & Experimental Allergy 41 (3): 346-356. https://doi.org/10.1111/j.1365-2222.2010.03638.x
Boyle, J.O., Z.H. Gümüs, A. Kacker, V.L. Choksi, J.M. Bocker, X.K. Zhou, R.K. Yantiss, et al. 2010. “Effects of Cigarette Smoke on the Human Oral Mucosal Transcriptome.” Cancer Prevention Research3 (3): 266-278.
Broaddus V.C. et al. 2016. Murray & Nadel's Textbook of Respiratory Medicine, 6th Edition. Elsevier.
D'Amelio, Jr., A.M., A. Cassidy, K. Asomaning, O.Y. Raji, S.W. Duffy, J.K. Field, M.R. Spitz, D Christiani, and CJ Etzel. 2010. “Comparison of Discriminatory Power and Accuracy of Three Lung Cancer Risk Models.” British Journal of Cancer103 (3): 423-429.
Davis, M.D., S.J. Fowler, and A.J. Montpetit. 2019. “Exhaled Breath Testing-A Tool for the Clinician and Researcher.” Paediatric Respiratory Reviews 29: 37-41. https://doi.org/10.1016/j.prrv.2018.05.002
Davis, M.D., and A.J. Montpetit. 2018. “Exhaled Breath Condensate.” Immunology and Allergy Clinics of North America 38 (4): 667-678. https://doi.org/10.1016/j.iac.2018.06.002
Dupree, E.J., M. Jayathirtha, H. Yorkey, M. Mihasan, B. Alina Petre, and C. C. Darie. 2020. “A Critical Review of Bottom-Up Proteomics: The Good, the Bad, and the Future of This Field.” Proteomes 8 (3): 14. https://doi.org/10.3390/proteomes8030014
Fumagalli, M., F. Ferrari, M. Luisetti, J. Stolk, P. Hiemstra, D. Capuano, S. Viglio, et al. 2012. “Profiling the Proteome of Exhaled Breath Condensate in Healthy Smokers and COPD Patients by LC-MS/MS.” International Journal of Molecular Sciences 13 (12): 13894-13910. https://doi.org/10.3390/ijms131113894
Fumagalli, M., L. Dolcini, A. Sala, J. Stolk, L. Fregonese, F. Ferrari, S. Viglio, M. Luisetti, and P. Iadarola. 2008. “Proteomic Analysis of Exhaled Breath Condensate from Single Patients with Pulmonary Emphysema Associated to Α1-Antitrypsin Deficiency.” Journal of Proteomics 71 (2): 211-221. https://doi.org/10.1016/j.jprot.2008.03.002
Gade, I.L., J.G. Schultz, L.J. Cehofski, B. Kjaergaard, M.T. Severinsen, B.S. Rasmussen, H. Vorum, B. Honoré, and S.R. Kristensen. 2021. “Exhaled Breath Condensate in Acute Pulmonary Embolism; a Porcine Study of Effect of Condensing Temperature and Feasibility of Protein Analysis by Mass Spectrometry.” Journal of Breath Research 15 (2): 026005. https://doi.org/10.1088/1752-7163/abd3f2
Gould, M.K. 2014. “Lung-Cancer Screening with Low-Dose Computed Tomography.” Edited by Caren G.S. New England Journal of Medicine 371 (19): 1813-1820. https://doi.org/10.1056/NEJMcp1404071
Griese, M., J. Noss, and C. von Bredow. 2002. “Protein Pattern of Exhaled Breath Condensate and Saliva.” Proteomics2 (6): 690-696. https://doi.org/10.1002/1615-9861(200206)2:6%3C690::AID-PROT690%3E3.0.CO;2-6
Han, W., T. Wang, A.A. Reilly, S. Keller, and S.D. Spivack. 2009. “Gene Promoter Methylation Assayed in Exhaled Breath, with Differences in Smokers and Lung Cancer Patients.” Respiratory Research10 (1): 86.
Kanodra, N.M., G.A. Silvestri, and N.T. Tanner. 2015. “Screening and Early Detection Efforts in Lung Cancer.” Cancer. 121(9): 1347-1356.
Kelly, R.S., A. Dahlin, M.J. McGeachie, W. Qiu, J. Sordillo, E.S. Wan, A.C. Wu, and J. Lasky-Su. 2017. “Asthma Metabolomics and the Potential for Integrative Omics in Research and the Clinic.” Chest 151 (2): 262-277.
Keskin, O., M.Y. Ozkars, B. Gogebakan, E. Kucukosmanoglu, M. Keskin, and H. Bayram. 2021. “Exhaled TGF-Beta1 Levels Before and After an Exercise Challenge in Asthmatic and Healthy Children, and During Exacerbation.” Journal of Asthma 58(3): 316-325.
Kononikhin, A.S., A.G. Brzhozovskiy, A.M. Ryabokon, K. Fedorchenko, N.V. Zakharova, A.I. Spasskii, I.A. Popov, et al. 2019. “Proteome Profiling of the Exhaled Breath Condensate after Long-Term Spaceflights.” International Journal of Molecular Sciences 20 (18): E4518. https://doi.org/10.3390/ijms20184518
Kononikhin, A.S., N.L. Starodubtseva, V.V. Chagovets, A.Y. Ryndin, A.A. Burov, I.A. Popov, A.E. Bugrova, et al. 2017. “Exhaled Breath Condensate Analysis from Intubated Newborns by Nano-HPLC Coupled to High-Resolution MS.” Journal of Chromatography B 1047: 97-105. https://doi.org/10.1016/j.jchromb.2016.12.036
Kubáň, P., and F. Foret. 2013. “Exhaled Breath Condensate: Determination of Non-Volatile Compounds and Their Potential for Clinical Diagnosis and Monitoring. A Review.” Analytica Chimica Acta 805: 1-18. https://doi.org/10.1016/j.aca.2013.07.049
Kurova, V.S., E.C. Anaev, A.S. Kononikhin, K.Y. Fedorchenko, I.A. Popov, T.L. Kalupov, D.O. Bratanov, E.N. Nikolaev, and S.D. Varfolomeev. 2009. “Proteomics of Exhaled Breath: Methodological Nuances and Pitfalls.” Clinical Chemistry and Laboratory Medicine 47 (6): 706-716. https://doi.org/10.1515/CCLM.2009.166
Lacombe, M., C. Marie-Desvergne, F. Combes, A. Kraut, C. Bruley, Y. Vandenbrouck, V. Chamel Mossuz, Y. Couté, and V. Brun. 2018. “Proteomic Characterization of Human Exhaled Breath Condensate.” Journal of Breath Research 12 (2): 021001. https://doi.org/10.1088/1752-7163/aa9e71
López-Sánchez, L.M., B. Jurado-Gámez, N. Feu-Collado, A. Valverde, A. Cañas, J.L. Fernández-Rueda, E. Aranda, and A. Rodríguez-Ariza. 2017. “Exhaled Breath Condensate Biomarkers for the Early Diagnosis of Lung Cancer Using Proteomics.” American Journal of Physiology. Lung Cellular and Molecular Physiology 313 (4): L664-L676. https://doi.org/10.1152/ajplung.00119.2017
Ma, L., J.E. Muscat, R. Sinha, D. Sun, and G. Xiu. 2021. “Proteomics of Exhaled Breath Condensate in Lung Cancer and Controls Using Data-Independent Acquisition (DIA): A Pilot Study.” Journal of Breath Research 15 (2). https://doi.org/10.1088/1752-7163/abd07e
Maniscalco, M., S. Fuschillo, D. Paris, A. Cutignano, A. Sanduzzi, and A. Motta. 2019. “Clinical Metabolomics of Exhaled Breath Condensate in Chronic Respiratory Diseases.” Advances in Clinical Chemistry 88: 121-149.
Molina-Pineko, S., R. Suarez, M.D. Pastor, and A. Nogal. 2012. “Association between the MiRNA Signatures in Plasma and Bronchoalveolar Fluid in Respiratory Pathologies.” Disease Markers 32 (4): 221-230.
Mozzoni, P., I. Banda, M. Goldoni, and M. Corradi. 2013. “Plasa and EBC MicroRNAs as Early Biomarkers of Non-Small-Cell Lung Cancer.” Biomarkers 18 (8): 679-686.
Muccilli, V., R. Saletti, V. Cunsolo, J. Ho, E. Gili, E. Conte, S. Sichili, C. Vancheri, and S. Foti. 2015. “Protein Profile of Exhaled Breath Condensate Determined by High-Resolution Mass Spectrometry.” Journal of Pharmaceutical and Biomedical Analysis 105: 134-149. https://doi.org/10.1016/j.jpba.2014.11.050
Nadal, E., A. Truini, A. Nakata, and J. Lin. 2015. “Novel Serum 4-MicroRNA Signature for Lung Cancer Detection.” Science Reports 5: 12464.
Oy, D.S.W., O.F. Agbaje, S.G. Baker, D.C. Christiani, A. Cassidy, and J.K. Field. 2012. “Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer: A Case-Control and Cohort Validation Study.” Ann Intern Med 157 (4): 242-250.
Peled, N., M. Hakim, P.A. Bunn, and Y.E. Miller. 2012. “Non-Invasive Breath Analysis of Pulmonary Nodules.” J Thor Oncology 7 (10): 1528-1533.
Perez-Rogers, J.F., J. Gerrein, C. Anderlind, G. Liu, S. Zhang, Y. Alekseyev, K.P. Smith, et al. 2017. “Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection.” JNCI: Journal of the National Cancer Institute 109 (7): djw327. https://doi.org/10.1093/jnci/djw327
Rom, W.N., J.G. Hay, T.C. Lee, Y. Jiang, and K.-M. Tchou-Wong. 2000. “Molecular and Genetic Aspects of Lung Cancer.” American Journal of Respiratory and Critical Care Medicine 161 (4): 1355-1367. https://doi.org/10.1164/ajrccm.161.4.9908012
Shi, M., W. Han, O. Loudig, C. Shah, J. Dobkin, S. Keller, A. Sadoughi, et al. 2021. “An Exhaled MicroRNA Panel Interrogated for Lung Cancer Case-Control Discrimination.” American Journal of Respiratory and Critical Care Medicine 203: A1077.
Silvestri, G.A., A. Vachani, D. Whitney, and M. Elashof. 2015. “A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.” NEJM 373 (3): 243-251.
Slavov, N. 2021. “Single-Cell Protein Analysis by Mass Spectrometry.” Current Opinion in Chemical Biology 60: 1-9. https://doi.org/10.1016/j.cbpa.2020.04.018
Spira, A., J.E. Beane, V. Shah, K. Steiling, G. Liu, F. Schembri, S. Gilman, et al. 2007. “Airway Epithelial Gene Expression in the Diagnostic Evaluation of Smokers with Suspect Lung Cancer.” Nature Medicine 13 (3): 361-366.
Spivack, S.D., M.J. Fasco, V.E. Walker, and L.S. Kaminsky. 1997. “The Molecular Epidemiology of Lung Cancer.” Critical Reviews in Toxicology 27 (4): 319-365. https://doi.org/10.3109/10408449709089898
Sridhar, S., F. Schembri, J. Zeskind, V. Shah, A.M. Gustafson, K. Steiling, G. Liu, et al. 2008. “Smoking-Induced Gene Expression Changes in the Bronchial Airway Are Reflected in Nasal and Buccal Epithelium.” BMC Genomics 9 (259). https://doi.org/10.1186/1471-2164-9-259
Sun, C., T. Zhou, G. Xie, S. Fu, L. Gao, J. Liao, Y. Wu, and G. Wang. 2019. “Proteomics of Exhaled Breath Condensate in Stable COPD and Non-COPD Controls Using Tandem Mass Tags (TMTs) Quantitative Mass Spectrometry: A Pilot Study.” Journal of Proteomics 206: 103392. https://doi.org/10.1016/j.jprot.2019.103392
The National Lung Screening Trial Research Team. 2011. “Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening.” New England Journal of Medicine 365 (5): 395-409. https://doi.org/10.1056/NEJMoa1102873
Vachani, A., C. Zheng, I.-L.A. Liu, B.Z. Huang, T.A. Osuji, and M.K. Gould. 2022. “The Probability of Lung Cancer in Patients With Incidentally Detected Pulmonary Nodules: Clinical Characteristics and Accuracy of Prediction Models.” Chest 161 (2): 562-571. https://doi.org/10.1016/j.chest.2021.07.2168
Walter, J.E, M.A Heuvelmans, K. ten Haaf, R. Vliegenthart, C. M. van der Aalst, U. Yousaf-Khan, P.M.A. van Ooijen, et al. 2019. “Persisting New Nodules in Incidence Rounds of the NELSON CT Lung Cancer Screening Study.” Thorax 74 (3): 247-253. https://doi.org/10.1136/thoraxjnl-2018-212152
Wozniak, M.B., G. Scelo, D.C. Muller, A. Mukeria, D. Zaridze, and P. Brennan. 2015. “Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.” PLoS One 10 (5). https://doi.org/10.1371/journal.pone.0125026
Zhang, X., P. Sebastiani, G. Liu, F. Schembri, X. Zhang, Y.M. Dumas, E.M. Langer, et al. 2010. “Similarities and Differences between Smoking-Related Gene Expression in Nasal and Bronchial Epithelium.” Physiological Genomics 41 (1): 1-8.